FDA grants breakthrough designation to Glytec’s Glucommander Pediatrics

Hospital Management · 13 hrs ago · 13 views

The US FDA has granted breakthrough device designation to Glytec’s proposed insulin dosing recommendation algorithm, Glucommander Pediatrics, for hospitalised newborns and infants under two years old. The post FDA grants breakthrough designation to Glytec’s Glucommander Pediatrics appeared first on Hospital Management.